Inify Laboratories Investor Relations Material

Inify Laboratories specializes in cancer diagnostics, focusing primarily on pathology services. Leveraging advanced technology, the company employs a fully digital, standardized, and AI-supported workflow designed to enhance both the quality and efficiency of diagnostic processes, initially targeting prostate cancer diagnostics. This comprehensive service encompasses the entire sample handling process, including logistics, preparation, and reporting. The company is headquartered in Solna, Sweden, and its shares are listed on the Oslo Stock Exchange.